Effectively harnessing the potential of health information technology (health IT) to improve patient safety, reduce harm, and improve patient outcomes remains a unifying national goal among healthcare providers, patients, and regulators. For several decades, the use of computer systems has been considered a potential mechanism to support and improve clinical care. 1 Through the Medicare and Medicaid Electronic Health Record (EHR) Incentive Program, known as the meaningful use program, the federal government is investing billions of dollars to promote the adoption of health IT in order to improve patient outcomes. 2 Rates of health IT adoption in the inpatient and outpatient settings are increasing, and the range of available technology remains vast and varied. 3 An important barrier to health IT adoption has been the uncertain effect on patient outcomes, particularly given the costliness of implementation of computerized infrastructures. 4 In order to evaluate the current state of the literature, we conducted a systematic review to determine the effect of multiple health IT tools on patient safety outcomes.
While 31 systematic reviews have been conducted with a focus on health IT interventions and patient safety outcomes, this systematic review is different for several reasons. First, many of the systematic reviews focused upon one specific health IT, [5] [6] [7] [8] [9] [10] most commonly clinical decision support (CDS). [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] Second, prior reviews often focused upon one area of clinical care such as outpatient, 13, 15, 27, 28 inpatient, 6, 16, 29 intensive care, 30 pediatrics, 5, 30 or geriatrics. 23 Other papers targeted very specific outcomes, such as the effects of health IT as it relates to antibiotic medications, 22 anticoagulant therapy, 20 lab testing, 7 or treatment of hypertension. 13 Finally, many prior reviews looked specifically at effects of health IT on one safety outcomeadverse drug events (ADEs). 5, 6, 19, 24, 26, 29, [31] [32] [33] Prior studies generally included both non-randomized and randomized trials. [4] [5] [6] [7] [8] [9] [15] [16] [17] [18] [19] [21] [22] [23] [27] [28] [29] [32] [33] [34] Eleven of the prior systematic reviews included only the highest level of evidence studies, randomized controlled trials (RCT). [10] [11] [12] [13] [14] 20, [24] [25] [26] 31, 35 Findings from these systematic reviews were mixed. Three of the previously mentioned 11 studies conducted a meta-analysis: 1 found improvement in patient safety outcomes, 24 1 stated insufficient studies to conclude, 26 and the final paper was equivocal. 10 Therefore, this systematic review serves to provide a cumulative picture of the effects of multiple types of health IT on an array of direct patient safety outcomes in all clinical areas. This is an important time to be studying health IT as adoption rates continue to rise, policymakers continue to support and promote its use, and the determination of how and when to begin regulation of health IT remains under debate. To our knowledge, no prior systematic review has evaluated a comprehensive set of health IT tools while also exclusively focusing on determining the effects of those technologies on direct patient safety outcomes. 
MATERIALS AND METHODS

Study Identification and Selection
Health IT was broadly defined as any automated or computerized system implemented to aid in the management of health information. We focused on the following health information technologies: computerized physician order entry (CPOE), e-prescribing, CDS, order entry alerts, EHR, health information exchange (HIE), patient portals, automated error detection software to detect medication errors (AED), electronic medication administration records (eMAR), medication administration barcodes, electronic medication reconciliation software (eMedRec), automated medication dispensing systems (AutoDisp), and electronic clinical pathways. Medication administration barcodes included barcode systems that dispense medication from an automated machine, as well as barcode systems that are used to ensure correct patient identification during the process of medication administration. Automated error detection systems referred to systems that look back to find the orders that may have led to an ADE or a pADE, in contrast to CPOE, which is designed to help aid the provider in correct prescribing at the point of care. We chose these tools through a combination of a priori knowledge of the literature, as well as health IT tools identified as part of the systematic review search process. Other patientcentered interventions such as health IT phone applications or home automated blood pressure cuff monitoring were not actively excluded; however, we did not identify any studies that assessed the impact of these technologies on direct patient outcomes. In cases in which authors did not identify the type of health IT employed using commonly known acronyms or terminology, reviewers used the description of the intervention to determine which type of health IT was being employed. The authors also identified the clinicians under study. For cases in which the clinicians employing a particular health IT intervention were not identified, the authors reported "NR," not reported. In cases where a clinician type was not applicable-for example, patient centered tools-those studies were denoted as N/A.
The patient outcomes chosen were identified from the studies included in the review, as well as from author knowledge of outcomes likely to be affected by health IT. After the analysis was completed, outcomes were then grouped on the basis of similar types of outcomes. In the articles for which more than one patient safety outcome was studied, reviewers included in the summary table only the primary outcome numerical effect size. However, for all outcomes, whether or not statistical significance was reached, the positive, negative, or nonsignificant effect on patient outcomes was considered and recorded (Table 1) .
We performed searches in bibliographic databases, Ovid Medline, Ovid EMBASE, the Cumulative Index to Nursing Allied Health (CINAHL) via Ebscohost, and Cochrane Library from January 2001 to June 2012. Conference proceedings were reviewed as well as bibliographies of selected articles. Citations of all identified prior systematic reviews were also reviewed. The search strategy included combinations of keywords and controlled vocabulary. A validated filter to represent patient safety was applied. 105 Appendix A illustrates the detailed search strategy for the four databases.
All citations, index terms, and abstracts (if available) were reviewed and rated as "potentially relevant" or "not relevant." In accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement for reporting of systematic reviews, one reviewer reviewed the entire set first of titles, followed by the abstracts. Articles that were potentially relevant were included in the set reviewed by 2 independent reviewers (see Figure 1) . 106 Articles were reviewed independently, and studies were included in the review if 1) the study participants were health professionals in clinical practice or postgraduate training, 2) the intervention was health IT studied in a clinical setting, and 3) the outcomes (even if secondary and not primary) that were assessed included at least one direct patient safety outcome (including any aspect of patient wellbeing, with process measures considered insufficient). Only Englishlanguage studies were included. All disagreements were resolved by consensus.
Study Evaluation
Two authors independently assessed all selected studies for methodological quality. A previously described 10-point Methodological Quality Assessment was adapted to the purposes of this study. 9, 11, 17 This methodological rating scale assesses for 5 potential sources of bias, each scored either 0, 1, or 2, including (A) the method of allocation to study groups (random vs selected concurrent controls vs non-concurrent controls), (B) the unit of allocation (ward or clinic vs physician vs patient), (C) baseline differences between groups which could potentially be linked to the study outcome (no baseline differences and/or appropriate statistical adjustments made for differences vs baseline differences apparent without statistical adjustment vs unable to assess), (D) the type of safety outcome measure (objective outcome or subjective outcome with blinded assessment vs objective outcome with no blinding vs subjective outcome without blinding of assessors), and (E) completeness of follow-up (>90% vs 80%-90% vs <80% and/or unable to assess). 11 As such, a score of 10 represents studies whose design had the lowest amount of bias (Table 2) . Disagreements were resolved by discussion to reach consensus. Reviewer agreement and inter-rater reliability was analyzed by the kappa statistical method. Since one reviewer reviewed all of the articles, and multiple reviewers were paired with the principal reviewer, a quadratic-weighted kappa was chosen. 107 Adopting the methodology employed by a prior systematic review (Chaudhry et al.) 4 , quantitative reports were considered "hypothesistesting" if the investigators compared data between groups or across time periods, using statistical tests to assess differences. We further categorized hypothesis-testing studies into 5 study types. RCTs were defined as studies that had a control and experimental arm for which the intervention (health IT) was randomly assigned. Cohort trials were defined as non-randomized studies for which a concurrent control arm was included. Observational studies were most often before-and-after studies in which the "before" group served as the only control. Time series analyses were studies for which time-series statistical analyses were conducted. Lastly, case-control studies were studies for which cases and controls were picked retrospectively, based on exposure to health IT. 4 
Data Extraction and Analysis
For each article included, both reviewers extracted information regarding patients, clinicians involved, setting, intervention, and outcomes for each of the studies. The safety outcomes evaluated were categorized into the following groups: 1) ADEs or adverse events (AEs); 2) mortality; 3) thrombosis or bleed; 4) length of stay (LOS); 5) infection rates; 6) readmission, admission, or emergency department (ED) visits; 7) fall rates or pressure ulcer; 8) hemodynamic instability or intensive care unit (ICU) transfer; 9) myocardial infarction (MI) or cardiac events; 10) chronic disease exacerbations; and 11) altered mental status (AMS) or stroke incidence.
Adapting methodology used in prior reviews, positive studies were those in which the primary outcome studied showed statistically significant improvement. Negative studies were those for which there were statistically significant worse patient safety outcomes. Mixed or 
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Unadjusted results showed reduction in both in-hospital mortality and 30-day mortality when order set was used.
Results adjusted for covariates were not found to be significant with use of CDS. Adjusted results were of borderline significance.
Gandhi et al.
. AEs M NS -There was no effect of rate ratios of ADEs in the pre-and post-CPOE implementation periods. There was a significantly decreased rate of potential ADEs in the control wards (with handwritten orders).
By contrast, medication error rates were also significantly reduced in the CPOE wards.
Kucher et al. (continued) (continued) . 4 Surgical site-infection rates were reduced compared with pre-study period, but not significantly reduced compared to concurrent controls when CDS was used to alert physicians to give intraoperative antibiotics.
a Primary outcomes noted with asterisks. non-significant studies were those for which the primary outcome had a non-significant result but secondary outcomes had a positive result, or studies in which all outcomes were non-significant. 15 Studies for which patient safety outcomes were not the primary outcome studied were included and the non-patient safety outcome endpoints were not analyzed. Consensus was reached during review discussions. A narrative synthesis method was used to integrate the findings into descriptive summaries. Sub-analyses of positive studies, mixed studies, and randomized controlled trials were conducted.
RESULTS
The search strategy identified 6138 articles. After removal of duplicate articles and articles available only in a foreign language, there were 4736 articles that underwent title review. Based on title alone, 817 (17%) were considered not appropriate for the study. Another 344 articles were added based on a review of the references of the systematic reviews found during the title review process. A total of 4263 articles then underwent abstract review, with 135 articles included for full two-person review. Sixty-eight articles met all of the study inclusion criteria (Figure 1 ).
Reviewer Agreement
Of the 135 papers reviewed by 2 reviewers, agreement about eligibility for inclusion in the systematic review was excellent 90.4% (k ¼ 80.9%; 95% CI, 71.0-90.8%). Of the 69 studies included in the final review, the level of chance-corrected agreement for scientific merit 
Descriptive Analysis of All Studies
Types of health IT and outcomes studied There was at least one article for every type of health IT pre-identified. More than one health IT was analyzed in 22 studies (31%), and in those cases, all of the health IT tools studied were included in the analysis. The most common health IT interventions were CDS (n ¼ 40) and CPOE (n ¼ 27) (Table 3) . Four health IT tools (electronic medication reconciliation, electronic clinical pathways, patient portal, and smart pumps) were included in only one study, and another 2 tools (HIE and automated medication dispensing) were only found in 2 studies each. The patient safety outcomes studied varied widely. The most common outcomes studied included: ADEs and adverse events (53% of studies), mortality (26%), thrombosis or bleed (14%), LOS (12%), and infection rates (10%). Secondary outcomes were included in the analysis to capture the broadest number of patient outcomes (Table 3) .
Study setting and participants
Most of the studies (n ¼ 59, 86%) were performed in inpatient settings. A multicenter study design was employed in 19 (28%) of the (31) 10 (14) 12 (17) 1 (1) Time Series 7 (10) 2 (3) 5 (7) - (86) 25 (36) 33 (48) 1 (1) Outpatient 10 (14) 1 (1) 9 (13) - (28) 4 (6) 15 (22) -
Clinicians Affected
Physicians 55 (80) 19 (28) 36 (52) 1 (1) Nurses 10 (14) 4 (6) 6 (9) - 27 (39) 10 (14) 16 (23) 1 (1) Automated error detection (26) 5 (7) 12 (18) 1 (1) Readmission, admission, or Emergency dept. visits
16 (24) 4 (6) 12 (18) Note: Studies can be counted in more than one category where applicable. Abbreviations: dept. ¼ department; ICU ¼ Intensive care unit.
Other category under clinicians refers to either not reported or not applicable study population.
studies with the majority (15 of these 19, 79%) of the multicenter trials resulting in non-significant clinical outcomes. Multicenter design was used in 75% (6 of 8) of outpatient studies as compared to only 22% (12 of 55) of inpatient studies. The vast majority (80%) of studies assessed physicians, rather than other healthcare practitioners and most studies were conducted in the United States (75%). There were studies for which authors did not specify the clinicians affected by their health IT, nor was it clear that clinicians were a subject under study from the text. In these cases, reviewers classified the clinicians as "NR," for not reported (Table 1 ).
Study quality
The study designs were roughly evenly distributed between RCTs, cohort, and observational design studies, with only a few time-series and case-control designed studies. Study quality was approximately evenly distributed across each grouping of ratings (0-3; 4-6; 7-10) ( Table 3) . Unlike prior studies, we did not find that there was a significant increase in the quality of studies over time. 11, 17 In terms of quality assessment, the weakest aspects of study design tended to be with regard to randomization and allocation. Specifically, the majority of studies failed to have randomization or even a concurrent control group as part of the study design, and most allocation was done at the patient, rather than unit level. Eighty-one percent of studies received a 1 for blinding of outcomes (which meant objective outcomes were assessed without blinding), and 61% of studies received a 2 for follow up (indicating >90% follow up achieved and reported). Reporting of baseline characteristics was variable and evenly distributed between scores of 0, 1, and 2. Notably, this pattern for quality assessment held true for all studies as well as in sub-analysis of positive vs mixed and negative studies Only 10 (24%) of the non-significant studies enrolled over 1000 patients whereas, 11 (44%) of the studies which found a positive effect of health IT on patient outcomes had enrolled more than 1000 patients (Table 4) . Larger studies (n > 1000 patients) were also more likely to be conducted more recently than smaller studies.
Effects of health IT on patient safety outcomes Of the 69 studies, the majority (n ¼ 43, 63%) had either non-significant findings with respect to patient safety outcomes, or mixed outcomes. Only 25 (36%) studies showed a statistically significant positive effect of health IT on the primary patient safety outcome assessed. There was also 1 (1%) study that found that health IT resulted in an increased mortality rate. There was a significant increase in the number of studies published on health IT and patient safety outcomes over time (Figure 2 ).
Analysis of Positive Studies
The 25 studies that found that health IT had a positive effect on the primary patient safety outcome were mostly observational trials (40%) or cohort trials (30%). The majority of the positive studies were single center trials (n ¼ 20), conducted in the United States (n ¼ 19).
The vast majority of studies that found a positive effect of health IT occurred in the inpatient setting (n ¼ 24, 96%). There was only one trial demonstrating a positive effect of health IT on patient safety outcomes in the outpatient setting, and none in the long-term care setting. There was no significant difference in the sample sizes or quality score of the positive studies as compared the mixed result or null studies (Table 3) .
Positive benefit on patient safety outcomes was demonstrated in studies evaluating CDS, CPOE, HIE, automated error detection, eMAR, medication administration barcodes, automated dispensing, and smart pumps. The health outcomes involved were adverse events (n ¼ 16 Methodological Quality Assessment Score 0-3 10 (23) 6 (14) 4 (9) 4-6 22 (51) 12 (28) 10 (23) 7-10 11 (26) 6 (14) 5 (12) Type of Health IT Intervention Studied
Clinical decision support (CDS) 26 (60) 15 (36) 11 (26) Computerized provider order entry (CPOE)
17 (40) 7 (16) 11 ( studies), mortality (n ¼ 4), LOS (n ¼ 4), readmission rates or ED visits (n ¼ 2), prevention or reduction of thrombosis or bleeding (n ¼ 2), infection rates (n ¼ 2), and rates of pressure ulcers or falls (n ¼ 2), AMS or stroke incidence (n ¼ 1), and hemodynamic instability or ICU admission (n ¼ 1). The patient safety outcomes for which there were more positive studies than mixed studies were LOS, renal impairment, and fall or pressure ulcer rates (Table 3) . In conducting further sub-analysis of the studies characterized as mixed results studies, it was found that more than half of those studies had non-significant findings with respect to all patient safety outcomes. The remaining studies categorized as mixed results had some secondary patient safety outcomes that were positive (Table 4) .
In order to determine which types of outcomes were positively affected by which types of health IT, the effective combinations of the two were analyzed. Overall, CDS, CPOE, or CPOE combined with CDS accounted for 73% of the interventions that were successful. The only health outcomes for which those health IT interventions did not constitute the majority was for infection rates, pressure ulcers, or hemodynamic instability or transfer to the ICU (Table 5 ).
Subgroup Analysis: RCTs Only
Of all the study types, RCTs had the smallest percentage of studies demonstrating positive effect of health IT on safety outcomes (n ¼ 5, 28%), as compared with all other studies (n ¼ 20, 40%). Again, as for the entire group of studies, inpatient studies, physician studies, and US studies were all more common among RCTs (Table 6 ). There was a much smaller increase in the number of RCT studies published over time, as compared to all studies (Figure 2 ).
The quality of the RCTs was significantly higher than the non-RCT studies (P < .001). The quality of the RCT studies did not improve over time (mean RTCs before 2003, 6.9 and after 2003, 7.2), unlike previously reported. 11, 17 Most RCTs studied patient mortality and readmission, admission, and ED visits. For these outcomes, only one study found a benefit of health IT (Table 6) . 102 
DISCUSSION
Overall Significance Our finding that most studies had mixed, rather than positive effects on patient safety outcomes, is consistent with almost all prior systematic reviews conducted on health IT and patient safety outcomes. We also found a paucity of outpatient studies, studies evaluating large numbers of patients, and randomized control trials. Given the national priority placed on adoption and use of health IT, our work highlights the urgent need to better evaluate the use of multiple types of health IT on a variety of patient safety outcomes and in a variety of healthcare settings.
Summary of Findings
Demonstrating the benefit of health IT is challenging for several reasons. First, adverse patient outcomes that can be expected to be modified by the implementation of health IT are generally rare events, necessitating large study samples. 108, 109 We only found 21 studies (31%) that had > 1000 patient study subjects. In addition, randomized control trials evaluating health IT are difficult to conduct, limiting the quality of evidence on this topic. Randomization is generally not feasible within an individual unit or practice, and thus has to be conducted Figure 2 : Number of studies published as a function of publication year. Even though the number of studies published on health information technology (IT) has increased significantly, the number of randomized controlled trials (RTC) published annually has only seen a modest increase over time.
across settings. In addition, health IT is costly to purchase, resourceintensive to implement and typically purchased for an entire practice or institution. Not surprisingly, we found that the rates of randomized control trials assessing the effects of health IT on patient safety outcomes are increasing more slowly than the rate of research on this topic overall (Figure 2) . Consistent with those constraints, in regards to the types of health IT studied, we found that CDS was the most commonly studied health IT intervention. This is likely due to its inherent nature-it is a software-based intervention that can be turned on and turned off, making it well suited for randomized control, before-and-after, or time series designs. Furthermore, because it is software-based it can be trialed at multiple institutions at once; as such, 63% of the multicenter trials focused on CDS. In contrast to CDS, however, many of the individual tools studied had only one or two quantitative publications.
We found only 10 studies conducted in the outpatient setting, despite the fact that the majority of care is given in the outpatient setting. 4, 110 Similarly, we found only 1 study conducted in the long-term care setting. While it has been shown that ambulatory care settings have until recently lagged behind larger institutions in engaging in health IT adoption, 111, 112 given the importance of primary care to population health and prevention, the ambulatory care setting stands to gain a lot from rigorous study of the use of health IT to improve patient safety outcomes.
Future Directions and Policy Implications
Given our findings, this review underscores important future directions for this field of research. First, additional large studies are needed to evaluate the effect of health IT on patient safety outcomes, particularly in the outpatient and long-term care settings. Second, a more uniform system for characterizing health IT tools will be needed to facilitate comparison between studies of health IT interventions. CDS, the most commonly studied health IT, for example, covers a very broad range of actual interventions. Third, as the field continues to develop, more cross-institutional studies and collaborations will be required in order to capture the impact of the newest of the emerging health IT tools, such as patient portals and HIE systems.
From a public policy perspective, discussions are occurring in both the academic community and among regulatory agencies as to how to best regulate health IT. The Federal, Food, Drug, and Cosmetic Act recently declared health IT a medical device under regulatory jurisdiction of the US Food and Drug Administration (FDA). 113 To date, the FDA has not yet exerted its regulatory authority over the vast majority of health IT tools. The Office of the National Coordinator for Health Information Technology has also published Safety Assurance Factors for EHR Resilience (SAFER) guides designed to help organizations assess and optimize health IT safety. 114 However, given the mixed findings of many research studies on the effects of health IT on patient safety outcomes, and one study demonstrating a hazardous effect, ongoing studies will be critical to ensure patients remain safe and to better determine which types and features of health IT actually improve care for patients.
Limitations
This review has several key limitations. The first is a direct correlate of the quantity and scope of the literature. Despite performing a comprehensive search, only a limited set of articles with quantitative data were identified. For many important types of health IT, only a few studies reporting the impact on actual patient outcomes were found, even among technologies that are being promoted by government policy. As with all systematic reviews, this review also faced the limitations imposed by publication bias, for which studies with positive results are more likely to be published than those with non-significant findings. Proportionally, however, we did find more studies with non-significant findings than not, which would suggest that our findings may be conservative in their estimate of the number of studies for which no significant effect of health IT was found. We also confined our search to English language publications, which may have precluded us from finding additional relevant studies. Given these limitations, it is possible that certain types of technology were underrepresented in this review, such as emerging technologies (like mobile technologies), patient portals, or HIE. For this review, we chose to use a quality scale that has been previously used and published in measuring the quality of the study of health IT. 9, 11, 17 While there are other widely utilized scales that might have been chosen, such as the Cochrane rating system, the scale we utilized has additional bias analysis categories not contained in other scales which we felt made it most rigorous for the quality analysis we were employing. Lastly, there is considerable heterogeneity as to what defines certain types of health IT. For example, CDS has become an umbrella term for many different types of decision support that can be implemented in different ways. We relied on authors' classifications for health IT tools in determining the type of health IT evaluated, rather than addressing this level of variability. This assumption may have led to an overrepresentation of CDS in the literature.
The authors also recognize that the impact of health IT is greatly influenced by technical, organizational, political, and social factors. Controlling for these in the context of a systematic review is extremely difficult given that authors of the original studies are often not able to measure or quantify these factors, and instead rely on well-matched controls to mitigate these effects. The rating system of study quality is the authors' attempt to guide readers as to which studies may most effectively control for larger, broader factors.
CONCLUSION
This review has important implications relevant to multiple stakeholders in healthcare, including providers, consumers, policymakers, and vendors. As the nation invests more heavily in health IT, understanding the effects on patient safety outcomes is critical. While there are certain health IT tools that are well studied and are demonstrating safety benefits for patients, there are many areas that are vastly understudied. This review underscores the need for additional, high quality, large-scale studies in multiple settings to better understand how health IT is actually impacting patients. Without such research, we will not be able to identify which health IT tools are indeed effective and in what settings we can expect the greatest benefit.
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